From €1348EUR$1,500USD£1,185GBP
- Report
- March 2023
- 80 Pages
South Korea
From €1348EUR$1,500USD£1,185GBP
- Report
- November 2025
China
From €3584EUR$3,990USD£3,152GBP
- Report
- November 2025
United Kingdom
From €3584EUR$3,990USD£3,152GBP
- Report
- November 2025
United Kingdom
From €3584EUR$3,990USD£3,152GBP
- Drug Pipelines
- March 2023
- 125 Pages
Global
From €13471EUR$14,995USD£11,845GBP
- Report
- November 2022
- 103 Pages
Global
From €3549EUR$3,950USD£3,120GBP
- Report
- November 2025
- 70 Pages
Mexico
From €1213EUR$1,350USD£1,066GBP
From €897EUR$999USD£789GBP
- Report
- April 2025
- 107 Pages
China
From €1617EUR$1,800USD£1,422GBP
- Report
- April 2025
- 54 Pages
China
From €1617EUR$1,800USD£1,422GBP
- Report
- March 2024
- 132 Pages
Global
From €853EUR$950USD£750GBP
- Report
- March 2024
- 132 Pages
Global
From €853EUR$950USD£750GBP
- Report
- August 2023
- 115 Pages
Global
From €4043EUR$4,500USD£3,555GBP
- Report
- March 2023
- 132 Pages
Global
From €853EUR$950USD£750GBP
- Report
- October 2022
- 25 Pages
Global
€11005EUR$12,250USD£9,677GBP
- Report
- October 2022
- 27 Pages
Global
€11005EUR$12,250USD£9,677GBP
- Report
- March 2020
- 49 Pages
Global
€1184EUR$1,318USD£1,041GBP
- Report
- August 2018
- 21 Pages
Global
From €8984EUR$10,000USD£7,900GBP
- Newsletter
- November 2025
China
€4851EUR$5,400USD£4,266GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more